Dr. Reuter Investor Relations
Dr. Reuter Investor Relations is a Frankfurt-based boutique IR consulting firm serving small-cap and mid-cap listed companies — especially North American issuers — seeking visibility in German and European capital markets through retainer-based IR, roadshow, and digital communications services.
- Company typePrivate
- Founded2019
- HeadquartersFrankfurt, Germany
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Dr. Reuter Investor Relations does
Dr. Reuter Investor Relations GmbH is a Frankfurt-headquartered, privately held German investor relations consulting agency that supports listed and pre-IPO companies in building visibility among German and broader European capital market audiences. The firm was founded by Dr. Eva Reuter (CEO) and operates with a small senior team — including CFO Christiane Gausler, Head of Global Markets Matthew Reynolds, Head of Editorial Content Sabine Lembert, Head of German-speaking Markets Sabine Nawotka, and Client Relationship Manager Nina Kutsche — from offices in Frankfurt (headquarters, Tower 185) and Münster.
The company's service offering is modular and includes roadshow organization, digital investor relations, institutional investor relationship building, financial media relations, capital market conference participation, and disclosure obligation management. Its core technology is limited to standard content publishing infrastructure (website, IR-Spotlight magazine, blog, newsletter, and social channels); the firm sells professional services, not software. Revenue is generated through monthly retainer-based consulting engagements, with initial terms typically running six months; pricing is engagement-specific, with one disclosed benchmark of €4,000 per month (Focus Graphite engagement). The firm serves a heterogeneous mix of 25+ clients across mining (Focus Graphite, St George Mining, Arcadia Minerals, Vulcan Energy), pharmaceuticals/biotech (Innocan Pharma, NurExone Biologic), water treatment (De.mem), construction (PORR), safety technology (Frequentis AG), and consumer/retail (Zalando), with a primary focus on small-cap and mid-cap issuers and non-European companies seeking DACH investor exposure.
Geographically, Dr. Reuter positions itself as a bridge between North American (particularly Canadian and US small-caps) and German-speaking capital markets (Germany, Austria, Switzerland), while distributing content globally via blog, magazine, newsletter, LinkedIn, Twitter, and Instagram. The company has no disclosed funding, no parent company, no subsidiaries, no patents, and no formal partnerships; it is a tightly-held founder-led boutique with no public revenue disclosure.
Dr. Reuter Investor Relations firmographics
Firmographics- Name
- Dr. Reuter Investor Relations
- Legal name
- Dr. Reuter Investor Relations GmbH
- Website
- https://dr-reuter.eu
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Dr. Reuter Investor Relations is a Frankfurt-based boutique IR consulting firm serving small-cap and mid-cap listed companies — especially North American issuers — seeking visibility in German and European capital markets through retainer-based IR, roadshow, and digital communications services.
- Ownership category
- akta.pro rank
Where Dr. Reuter Investor Relations is headquartered
LocationHeadquarters
- HQ city
- Frankfurt
- HQ country
- Germany
- HQ region
- Europe
Offices2 records
Markets served
Dr. Reuter Investor Relations business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- IR Consulting Services: Monthly retainer-based consulting engagements for investor awareness and communications services across Germany and European capital markets. Initial engagements typically run for six-month terms. Pricing mentioned at €4,000 per month for Focus Graphite engagement.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Monthly | Standard IR consulting engagement |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
Dr. Reuter Investor Relations product offering
Product offeringCore offering
Dr. Reuter Investor Relations is a Frankfurt-based professional services firm that provides investor relations (IR) consulting, financial communications, and digital IR solutions to listed companies. The firm offers a modular suite of services including roadshow organization, digital investor relations, institutional investor relationship building, financial media relations, capital market conference participation, and disclosure obligation management, focused on European capital markets and German-speaking markets.
Product overview
Dr. Reuter Investor Relations is a professional investor relations agency providing comprehensive IR consulting services across European capital markets, with a focus on German-speaking markets and the broader EU region. The company offers a modular suite of investor relations services including roadshows, digital investor relations, institutional investor relationship building, financial media relations, capital market conferences, and disclosure obligation management. Services are delivered to both private and institutional investors globally, with particular emphasis on the US and European markets. All services can be engaged on a modular basis tailored to client needs, or as part of long-term relationships. The company publishes the IR Spotlight magazine as part of its thought leadership content, and maintains professional articles on investor relations topics.
Differentiator
Problem solved
Functional benefit
Products and services
- Investor Relations Consulting Services Modular retainer-based IR consulting engagements covering roadshows, digital investor relations, institutional investor relationship building, financial media relations, capital market conferences, and disclosure obligation management. Targeted at small-cap and mid-cap listed companies seeking visibility in European capital markets, particularly Germany, Austria, and Switzerland.
- Roadshow Organization Planning and execution of investor roadshows for listed companies targeting private and institutional investors across global capital markets, with emphasis on US and European exchanges.
- Digital Investor Relations Digital IR communications services for listed companies, including online investor engagement, digital roadshows, and online roundtables.
- Financial Media Relations Financial-PR services including editorial contributions and media engagement with German and European financial press.
- IR-Spotlight Magazine Quarterly magazine covering investor relations trends, institutional IR, IR insights, and ESG topics, distributed as part of the firm's thought leadership content.
Quantifiable outcome
- German trading volume increased from 22.6% to 41.4% for PORR with nearly 500% increase in trading volume on German stock exchanges
- +2 more outcomes
Companies that use Dr. Reuter Investor Relations
Customer profileNamed customers10 records
Segments3 records
Ideal customer profiles2 records
Dr. Reuter Investor Relations technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Dr. Reuter Investor Relations partnerships and signals
Strategic signalScale indicators2 records
Recent moves5 records
Expansion highlights5 records
Dr. Reuter Investor Relations competitors and assessment
Company assessmentDirect peers
- MC Services AG: Munich-based international investor relations and corporate communications firm focused on European small and mid-cap healthcare, technology, and growth companies. Direct competitor in serving non-European (especially North American) issuers seeking DACH investor visibility.
- cometis AG: German investor relations and corporate communications agency headquartered in Wiesbaden, serving small and mid-cap listed companies across DACH. Directly competes with Dr. Reuter for the same cross-Atlantic IR mandate segment and offers comparable retainer-based roadshow and media relations services.
- IR.on AG: Cologne-based IR consulting firm providing investor relations, financial communications, and ESG advisory to German and European listed companies. Highly comparable in size, client segment (small/mid-caps), and service mix including roadshows, capital markets days, and media relations.
- Kirchhoff Consult AG: Hamburg-headquartered financial communications and investor relations consultancy serving DACH-listed companies. Overlaps with Dr. Reuter on IR advisory, ESG communications, and capital markets support, but with a larger team and broader client roster including DAX issuers.
- Better Orange IR & HV AG: German full-service IR and annual general meeting (Hauptversammlung) specialist supporting DAX, MDAX, and SDAX issuers. Overlaps with Dr. Reuter on disclosure and shareholder communications but with deeper AGMVote / virtual AGM technology capabilities.
Broad incumbents
- Edelman Smithfield: Global financial communications and investor relations arm of Edelman, with a German presence. Competes for cross-Atlantic IR mandates and capital markets advisory but at significantly larger scale and broader geographic footprint than Dr. Reuter.
- Brunswick Group: International corporate communications and investor relations advisory with deep European capital markets expertise. Overlaps with Dr. Reuter on M&A and capital markets IR advisory but typically serves large-cap clients with multi-jurisdictional needs.
- DGAP (Deutsche Gesellschaft für Ad-hoc-Publizität) / EQS Group: Leading European provider of regulatory disclosure, investor relations software, and compliance services for listed companies. Competes with Dr. Reuter in disclosure obligation management and IR workflow tooling, but operates as a scaled platform with hundreds of employees.
- FGS Global (formerly FTI Consulting / Hering Schuppener): Global strategic communications and investor relations firm with a strong Frankfurt office (formerly Hering Schuppener). Serves large-cap and mid-cap DACH issuers with full-service IR advisory, transactions communications, and crisis support — a much larger competitor to Dr. Reuter on enterprise mandates.
Emerging players
- ICR (ICR Westwicke): US-headquartered strategic communications and IR advisory with growing European presence, focused on healthcare and technology small/mid-caps. Comparable to Dr. Reuter in serving growth-oriented issuers but with a North American home base and a transatlantic remit.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Dr. Reuter Investor Relations social profiles
Digital presenceDr. Reuter Investor Relations financial estimates
Financial estimateRevenue estimate
Valuation estimate
Dr. Reuter Investor Relations leadership team
Management profileNumber of profiles
Profiles1 record
Dr. Reuter Investor Relations funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Dr. Reuter Investor Relations M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Dr. Reuter Investor Relations
What does Dr. Reuter Investor Relations do?
Dr. Reuter Investor Relations is a Frankfurt-based professional services firm that provides investor relations (IR) consulting, financial communications, and digital IR solutions to listed companies. The firm offers a modular suite of services including roadshow organization, digital investor relations, institutional investor relationship building, financial media relations, capital market conference participation, and disclosure obligation management, focused on European capital markets and German-speaking markets.
Is Dr. Reuter Investor Relations a public or private company?
Dr. Reuter Investor Relations is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Dr. Reuter Investor Relations founded?
Dr. Reuter Investor Relations was founded in 2019. It employs 1 to 10 people.
Where is Dr. Reuter Investor Relations based?
Dr. Reuter Investor Relations is headquartered in Frankfurt, Germany, in the Europe region.
How does Dr. Reuter Investor Relations make money?
One revenue line is on record: IR Consulting Services.
Who are Dr. Reuter Investor Relations's main competitors?
Direct peers on record are MC Services AG, cometis AG, IR.on AG, Kirchhoff Consult AG and Better Orange IR & HV AG. Broad incumbents are Edelman Smithfield, Brunswick Group, DGAP (Deutsche Gesellschaft für Ad-hoc-Publizität) / EQS Group and FGS Global (formerly FTI Consulting / Hering Schuppener). ICR (ICR Westwicke) is listed as an emerging player.
Does Dr. Reuter Investor Relations have an API?
No public API is recorded for Dr. Reuter Investor Relations.